Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele A Cleary

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|October 18, 2008
Combinatorial microRNAs: working together to make a differenceIrena Ivanovska, Michele A Cleary
Cell Cycle (Georgetown, Tex.)|September 6, 2007
MicroRNAs and cell cycle regulationMichael Carleton, Michele A Cleary, Peter S Linsley
RNA (New York, N.Y.)|March 30, 2010
Reduced seed region-based off-target activity with lentivirus-mediated RNAiRichard A Klinghoffer, Jill Magnus, Janell Schelter, et al.
Assay and Drug Development Technologies|January 22, 2008
An optimized lentivirus-mediated RNAi screen reveals kinase modulators of kinesin-5 inhibitor sensitivityRichard A Klinghoffer, Brian Roberts, James Annis, et al.
Nature Biotechnology|December 28, 2004
Synthetic shRNAs as potent RNAi triggersDespina Siolas, Cara Lerner, Julja Burchard, et al.
Current Biology : CB|November 26, 2008
Global survey of genomic imprinting by transcriptome sequencingTomas Babak, Brian Deveale, Christopher Armour, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 7, 2012
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γPaul Warrener, Sammy Kim, Sybil M G Williams, et al.
Cancer Research|February 5, 2009
Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analysesB Nelson Chau, Robert L Diaz, Matthew A Saunders, et al.
Molecular and Cellular Biology|August 8, 2012
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse modelJoyoti Dey, Sally Ditzler, Sue E Knoblaugh, et al.
Cancer Biology & Therapy|August 19, 2008
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA clusterElaine Y Chung, Michael Dews, Diana Cozma, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|October 18, 2008
Combinatorial microRNAs: working together to make a differenceIrena Ivanovska, Michele A Cleary
Cell Cycle (Georgetown, Tex.)|September 6, 2007
MicroRNAs and cell cycle regulationMichael Carleton, Michele A Cleary, Peter S Linsley
RNA (New York, N.Y.)|March 30, 2010
Reduced seed region-based off-target activity with lentivirus-mediated RNAiRichard A Klinghoffer, Jill Magnus, Janell Schelter, et al.
Assay and Drug Development Technologies|January 22, 2008
An optimized lentivirus-mediated RNAi screen reveals kinase modulators of kinesin-5 inhibitor sensitivityRichard A Klinghoffer, Brian Roberts, James Annis, et al.
Nature Biotechnology|December 28, 2004
Synthetic shRNAs as potent RNAi triggersDespina Siolas, Cara Lerner, Julja Burchard, et al.
Current Biology : CB|November 26, 2008
Global survey of genomic imprinting by transcriptome sequencingTomas Babak, Brian Deveale, Christopher Armour, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 7, 2012
Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γPaul Warrener, Sammy Kim, Sybil M G Williams, et al.
Cancer Research|February 5, 2009
Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analysesB Nelson Chau, Robert L Diaz, Matthew A Saunders, et al.
Molecular and Cellular Biology|August 8, 2012
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse modelJoyoti Dey, Sally Ditzler, Sue E Knoblaugh, et al.
Cancer Biology & Therapy|August 19, 2008
c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA clusterElaine Y Chung, Michael Dews, Diana Cozma, et al.
Pageof 4